Résultats de la recherche - 33 results

Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.

cervical intraepithelial neoplasia of grade 3 or worse (CIN3 +). METHODS: A literature search was conducted in 3 bibliographic databases. Studies were selected if they included women with ASC- US or LSIL who ...

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.

suivi de la dysplasie cervicale. Lors du dépistage, les auteurs des lignes directrices ou les envoyer à un kit de collecte automatique du VPH. Les tests de dépistage HPP 16 ou HPV 18 sont positifs. Un ...

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial ...

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

types and women unselected by HPV  status. Expert commentary:  All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

1.04) for cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) and 1.01 (95% CI, 0.97 to 1.06) for CIN3 + and relative specificity of 1.02 (95% CI, 1.00 to 1.03) for a CIN grade of ≤1. The ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Alphapapillomavirus Cervical Intraepithelial Neoplasia Cervix Uteri Diagnostic Tests, Routine DNA, Viral Early Detection of Cancer Female Genotyping Techniques Humans Papillomavirus Infections Uterine Cervical ...

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

ANALYSIS: We used Cochrane methodology and GRADE to rate the certainty of evidence for protection against cervical precancer (cervical intraepithelial neoplasia grade 2 and above [CIN2 +], CIN grade 3 and ...

QR code

QR code for this page URL